JP2012530510A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012530510A5 JP2012530510A5 JP2012516777A JP2012516777A JP2012530510A5 JP 2012530510 A5 JP2012530510 A5 JP 2012530510A5 JP 2012516777 A JP2012516777 A JP 2012516777A JP 2012516777 A JP2012516777 A JP 2012516777A JP 2012530510 A5 JP2012530510 A5 JP 2012530510A5
- Authority
- JP
- Japan
- Prior art keywords
- fusion protein
- amino acid
- acid residues
- endolysin
- gram
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP09163955 | 2009-06-26 | ||
| EP09163955.9 | 2009-06-26 | ||
| PCT/EP2010/059152 WO2010149795A1 (en) | 2009-06-26 | 2010-06-28 | Antimicrobial agents |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016131194A Division JP2017018092A (ja) | 2009-06-26 | 2016-07-01 | 抗微生物剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012530510A JP2012530510A (ja) | 2012-12-06 |
| JP2012530510A5 true JP2012530510A5 (enExample) | 2013-08-15 |
| JP6034188B2 JP6034188B2 (ja) | 2016-11-30 |
Family
ID=42537604
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012516777A Active JP6034188B2 (ja) | 2009-06-26 | 2010-06-28 | 抗微生物剤 |
| JP2016131194A Pending JP2017018092A (ja) | 2009-06-26 | 2016-07-01 | 抗微生物剤 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016131194A Pending JP2017018092A (ja) | 2009-06-26 | 2016-07-01 | 抗微生物剤 |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US20120195872A1 (enExample) |
| EP (2) | EP3363896A1 (enExample) |
| JP (2) | JP6034188B2 (enExample) |
| KR (1) | KR101701890B1 (enExample) |
| CN (1) | CN102482655B (enExample) |
| AU (1) | AU2010264659B2 (enExample) |
| BR (1) | BRPI1015203B1 (enExample) |
| CA (1) | CA2765810C (enExample) |
| EA (1) | EA038542B1 (enExample) |
| IL (1) | IL217121B (enExample) |
| MX (1) | MX2011013453A (enExample) |
| SG (1) | SG177704A1 (enExample) |
| WO (1) | WO2010149795A1 (enExample) |
Families Citing this family (49)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG177370A1 (en) | 2009-06-26 | 2012-02-28 | Univ Leuven Kath | Antimicrobial agents |
| BRPI1015203B1 (pt) | 2009-06-26 | 2021-06-01 | Lysando Ag | Proteína de fusão composta por uma endolisina e uma extensão de peptídeo anfifática, usos da mesma e composição farmacêutica que compreende a dita proteína |
| EP2470648B1 (en) | 2009-08-24 | 2019-04-10 | Katholieke Universiteit Leuven K.U. Leuven R&D | New endolysin obpgplys |
| ES2703629T3 (es) * | 2010-09-17 | 2019-03-11 | Tecnifar Ind Tecnica Farmaceutica S A | Fago antibacteriano, péptidos de fago y métodos de uso de los mismos |
| EP2468856A1 (en) * | 2010-12-23 | 2012-06-27 | Lysando Aktiengesellschaft | Antimicrobial Agents |
| CN102766196B (zh) * | 2011-05-06 | 2014-10-29 | 上海医药工业研究院 | 一组阳离子抗菌肽及其制备方法和应用 |
| CN103361341B (zh) * | 2012-03-26 | 2015-09-02 | 复旦大学附属华山医院 | 杀菌肽ll-37的基因工程的表达及其制备方法和用途 |
| US9388400B2 (en) | 2012-06-29 | 2016-07-12 | Lysando Ag | Composition for use in mycobacteria diagnosis |
| EP2679677A1 (en) * | 2012-06-29 | 2014-01-01 | Lysando Aktiengesellschaft | Composition for use in Mycobacteria therapy |
| EP2679232A1 (en) * | 2012-06-29 | 2014-01-01 | Lysando Aktiengesellschaft | Composition for use in Mycobacteria vaccination |
| CN105579053B (zh) * | 2013-08-06 | 2021-08-31 | 达特茅斯学院理事会 | 非糖基化溶葡球菌素变体蛋白 |
| WO2015070911A1 (en) | 2013-11-14 | 2015-05-21 | Lysando Ag | Modified kz144 endolysin sequence |
| WO2015070912A1 (en) | 2013-11-14 | 2015-05-21 | Lysando Ag | Modified el188 endolysin sequence |
| EP2904912A1 (en) * | 2014-02-07 | 2015-08-12 | Hyglos Invest GmbH | Novel high pressure method with endolysin for processing of foods |
| US10329550B2 (en) | 2014-02-14 | 2019-06-25 | Lysando Ag | Antimicrobial agents |
| DK3185882T3 (da) | 2014-08-29 | 2020-01-27 | Region Midtjylland | Positivt ladede copolymerer til anvendelse som antimikrobielle midler |
| WO2016130024A1 (en) * | 2015-02-13 | 2016-08-18 | Supreme Biotechnologies Limited | Endolysin expression platform |
| CN109072211B (zh) * | 2016-04-28 | 2023-10-27 | 莱桑多股份公司 | 抗沙门氏菌的抗菌剂 |
| MX2019004439A (es) * | 2016-10-20 | 2019-09-26 | Lysando Ag | Nuevos agentes antimicrobianos contra las bacterias enterococcus. |
| US11208643B2 (en) * | 2017-04-03 | 2021-12-28 | Sasinapas Co., Ltd. | Engineered gram-negative endolysins |
| CN108018271B (zh) * | 2018-01-31 | 2020-08-11 | 武汉核圣生物技术有限公司 | 单亚基rna聚合酶、其纯化方法及在rna合成中的应用 |
| KR20200136980A (ko) * | 2018-03-29 | 2020-12-08 | 콘트라펙트 코포레이션 | 리신-항미생물 펩타이드(amp) 폴리펩타이드 작제물, 리신, 이를 인코딩하는 단리된 폴리뉴클레오타이드 및 이의 용도 |
| EP3802814A1 (en) | 2018-05-30 | 2021-04-14 | Lysando AG | Novel antimicrobial proteins |
| BR112020018787A2 (pt) * | 2018-08-23 | 2021-03-09 | Contrafect Corporation | Constructos de polipeptídeo de lisina-peptídeo antimicrobiano (amp), lisinas, polinucleotídeos isolados que codificam os mesmos e usos dos mesmos |
| WO2021087415A1 (en) * | 2019-10-31 | 2021-05-06 | University Of Maryland, College Park | Method of treating infections by bacteriolytic enzymes and manufacture thereof |
| MX2022010725A (es) * | 2020-03-02 | 2022-09-23 | Unilever Ip Holdings B V | Una composicion efectiva para el cuidado personal anti-acne. |
| CN115942932A (zh) | 2020-03-19 | 2023-04-07 | 迈克瑞欧斯人体健康有限公司 | 感兴趣的稳定蛋白 |
| WO2022166736A1 (zh) | 2021-02-08 | 2022-08-11 | 武汉乐斯吉生物科技有限公司 | 噬菌体裂解酶、其嵌合物及应用 |
| US12171814B2 (en) | 2021-04-19 | 2024-12-24 | MVRIX Co., Ltd. | Protein complex including botulinum toxin translocation domain and endolysin and antibacterial composition including same |
| WO2023168418A1 (en) * | 2022-03-03 | 2023-09-07 | Massachusetts Institute Of Technology | Cell-wall binding protein specifically targeting cutibacterium acnes |
| CN114349870B (zh) * | 2022-03-21 | 2022-06-03 | 天津辅元生物医药科技有限公司 | 一种兼具防粘连功效的重组抗菌肽及其制备方法和应用 |
| CN114540385B (zh) * | 2022-03-21 | 2023-06-23 | 齐鲁工业大学 | 一种利用大肠杆菌产溶葡萄球菌酶的方法 |
| WO2024241070A1 (en) | 2023-05-22 | 2024-11-28 | L'oreal | Cosmetic composition comprising an endolysin and a polyvinyl alcohol |
| FR3149203A1 (fr) | 2023-06-02 | 2024-12-06 | L'oreal | Composition anhydre comprenant une endolysine et de l’hydroxypropylmethylcellulose et/ou du pullulane |
| FR3152395A1 (fr) | 2023-08-28 | 2025-03-07 | L'oreal | Composition cosmétique comprenant une endolysine dérivée de phage de Staphylococcus aureus et la 4-hydroxyacetophenone |
| FR3149208A1 (fr) | 2023-06-02 | 2024-12-06 | L'oreal | Composition cosmétique, notamment aqueuse, comprenant une endolysine et un pullulane |
| FR3149209A1 (fr) | 2023-06-02 | 2024-12-06 | L'oreal | Composition cosmétique comprenant une endolysine dérivée de phage de Staphylococcus aureus et un alcool aromatique |
| WO2024246325A1 (en) | 2023-06-02 | 2024-12-05 | L'oreal | Cosmetic composition comprising an endolysin derived from a staphylococcus aureus phage and an aromatic alcohol |
| FR3149206A1 (fr) | 2023-06-02 | 2024-12-06 | L'oreal | Composition cosmétique aqueuse comprenant une endolysine et du tréhalose |
| FR3149205A1 (fr) | 2023-06-02 | 2024-12-06 | L'oreal | Composition cosmétique comprenant une endolysine et un agent de charge organique |
| FR3149207A1 (fr) | 2023-06-02 | 2024-12-06 | L'oreal | Composition cosmétique comprenant une endolysine et un composé de formule (I) |
| FR3149204A1 (fr) | 2023-06-02 | 2024-12-06 | L'oreal | Composition cosmétique comprenant une endolysine et un tensioactif non ionique comprenant un résidu carbohydrate |
| FR3149202A1 (fr) | 2023-06-02 | 2024-12-06 | L'oreal | Composition cosmétique comprenant une endolysine dérivée de phage de Staphylococcus aureus et une huile. |
| FR3152393A1 (fr) | 2023-08-28 | 2025-03-07 | L'oreal | Composition cosmétique comprenant une endolysine dérivée d’un phage de Staphylococcus aureus et une charge minérale |
| FR3152396A1 (fr) | 2023-08-28 | 2025-03-07 | L'oreal | Composition cosmétique comprenant une endolysine dérivée de phage de Staphylococcus aureus et un polyhydroxyalcane |
| FR3152394A1 (fr) | 2023-08-28 | 2025-03-07 | L'oreal | Composition cosmétique comprenant une endolysine et des particules d’aérogel de silice hydrophobe |
| WO2025093666A1 (en) | 2023-11-01 | 2025-05-08 | University Of Copenhagen | Treatment of lymphoma |
| CN118421604B (zh) * | 2024-05-27 | 2024-10-22 | 小白鲸(中山)生物医药有限公司 | 一种重组溶葡萄球菌酶突变体及其制备方法和应用 |
| CN119799685A (zh) * | 2024-12-27 | 2025-04-11 | 深圳先进技术研究院 | 一种靶向闪烁梭菌的抗菌蛋白及其制备方法与应用 |
Family Cites Families (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR970006154B1 (ko) | 1987-07-06 | 1997-04-24 | 루이지아나 스테이트 유니버시티 아그리컬춰럴 앤드 메카니칼 컬리지 | 용해성 펩티드에 의한 진핵 병원체와 신생물의 억제 및 섬유아세포와 임파구의 자극 |
| GB8816693D0 (en) | 1988-07-13 | 1988-08-17 | Agricultural & Food Res | Viral enzyme & gene |
| GB2255561B (en) | 1991-04-20 | 1995-06-21 | Agricultural & Food Res | Lysins from bacteriophages |
| DE69332740T2 (de) | 1992-08-21 | 2004-02-05 | The University Of British Columbia, Vancouver | Kationische peptide und verfahren zu deren herstellung |
| DE69519675T2 (de) | 1994-09-01 | 2001-09-13 | Novozymes A/S, Bagsvaerd | Eine grundlegende proteinzusammensetzung zur abtötung oder inhibierung mikrobieller zellen |
| US6503881B2 (en) * | 1996-08-21 | 2003-01-07 | Micrologix Biotech Inc. | Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics |
| US6428784B1 (en) | 1997-10-31 | 2002-08-06 | New Horizons Diagnostics Corp | Vaginal suppository for treating group B Streptococcus infection |
| US20030113298A1 (en) | 1997-10-31 | 2003-06-19 | Vincent Fischetti | Use of bacterial phage associated lysing proteins for the prophylactic and therapeutic treatment of various illnesses |
| US5997862A (en) | 1997-10-31 | 1999-12-07 | New Horizons Diagnostics Corporation | Therapeutic treatment of group A streptococcal infections |
| US6288212B1 (en) | 1998-08-28 | 2001-09-11 | The University Of British Columbia | Anti-endotoxic, antimicrobial cationic peptides and methods of use therefor |
| US5993809A (en) * | 1998-11-18 | 1999-11-30 | Children's Hospital Medical Center | Lysozyme fusion proteins in infections |
| EP1194570A1 (en) | 1999-06-23 | 2002-04-10 | PPL Therapeutics (Scotland) Limited | Fusion proteins incorporating lysozyme |
| US7338936B2 (en) | 2000-11-28 | 2008-03-04 | House Ear Institute | Use of antimicrobial proteins and peptides for the treatment of otitis media and paranasal sinusitis |
| DE60329382D1 (de) | 2002-04-22 | 2009-11-05 | Dow Global Technologies Inc | Kostengünstige herstellung von peptiden |
| US7566447B2 (en) | 2003-05-15 | 2009-07-28 | Iogenetics, Llc | Biocides |
| NZ545564A (en) | 2003-09-11 | 2008-07-31 | Novozymes As | Recombinant production of antimicrobial agents |
| WO2005108563A2 (en) | 2004-04-19 | 2005-11-17 | University Of Chicago | Peptidoglycan-hydrolyzing protein encoded by bacteriophage n4 |
| US7572602B1 (en) | 2004-12-03 | 2009-08-11 | The United States Of America As Represented By The Secretary Of Agriculture | Nucleic acid encoding endolysin fusion protein |
| DE102005040347A1 (de) | 2005-08-25 | 2007-03-01 | Profos Ag | Verfahren und Mittel zur Anreicherung, Entfernung und zum Nachweis von Listerien |
| EP2004215B1 (en) | 2006-03-31 | 2010-06-09 | The University Court of the University of St. Andrews | Anti-microbial compositions comprising a cationic peptide and a glycylglycine endopeptidase |
| DE102006061002A1 (de) | 2006-12-22 | 2008-06-26 | Profos Ag | Verfahren und Mittel zur Anreicherung, Entfernung und zum Nachweis von gram-positiven Bakterien |
| BRPI0817299A8 (pt) * | 2007-09-25 | 2019-01-29 | Pastoral Greenhouse Gas Res Limited | vacinas e componentes de vacina para inibição de células microbianas |
| US20100310522A1 (en) | 2007-11-26 | 2010-12-09 | Plant Bioscience Limited | Novel Polypeptides Having Endolysin Activity and Uses Thereof |
| AU2009273845B2 (en) | 2008-07-24 | 2016-02-04 | The United State Of America, As Represented By The Secretary Of Agriculture | Triple acting antimicrobials that are refractory to resistance development |
| EP2157100A1 (en) * | 2008-08-19 | 2010-02-24 | Profos AG | Artificial peptidoglycan lysing enzymes and peptidoglycan binding proteins |
| GB0815484D0 (en) * | 2008-08-26 | 2008-10-01 | Univ Leuven Kath | Antibacterial agents |
| US8389679B2 (en) | 2009-02-05 | 2013-03-05 | The Regents Of The University Of California | Targeted antimicrobial moieties |
| DE102010014867A1 (de) * | 2009-04-17 | 2010-11-18 | Sms Siemag Ag | Verfahren zum Bereitstellen mindestens einer Arbeitswalze zum Walzen eines Walzguts |
| US8383102B2 (en) | 2009-05-21 | 2013-02-26 | The United States Of America As Represented By The Secretary Of Agriculture | Fusion of peptidoglycan hydrolase enzymes to a protein transduction domain allows eradication of both extracellular and intracellular gram positive pathogens |
| BRPI1015203B1 (pt) | 2009-06-26 | 2021-06-01 | Lysando Ag | Proteína de fusão composta por uma endolisina e uma extensão de peptídeo anfifática, usos da mesma e composição farmacêutica que compreende a dita proteína |
| SG177370A1 (en) | 2009-06-26 | 2012-02-28 | Univ Leuven Kath | Antimicrobial agents |
| EP2470648B1 (en) | 2009-08-24 | 2019-04-10 | Katholieke Universiteit Leuven K.U. Leuven R&D | New endolysin obpgplys |
| MX340520B (es) | 2010-04-27 | 2016-07-12 | Lysando Ag * | Metodo de reduccion de biopeliculas. |
| US9388400B2 (en) * | 2012-06-29 | 2016-07-12 | Lysando Ag | Composition for use in mycobacteria diagnosis |
-
2010
- 2010-06-28 BR BRPI1015203-2A patent/BRPI1015203B1/pt active IP Right Grant
- 2010-06-28 WO PCT/EP2010/059152 patent/WO2010149795A1/en not_active Ceased
- 2010-06-28 AU AU2010264659A patent/AU2010264659B2/en active Active
- 2010-06-28 CA CA2765810A patent/CA2765810C/en active Active
- 2010-06-28 SG SG2012003745A patent/SG177704A1/en unknown
- 2010-06-28 JP JP2012516777A patent/JP6034188B2/ja active Active
- 2010-06-28 US US13/380,329 patent/US20120195872A1/en not_active Abandoned
- 2010-06-28 EA EA201270082A patent/EA038542B1/ru unknown
- 2010-06-28 EP EP18165516.8A patent/EP3363896A1/en active Pending
- 2010-06-28 EP EP10727421.9A patent/EP2446028B1/en active Active
- 2010-06-28 CN CN201080037886.7A patent/CN102482655B/zh active Active
- 2010-06-28 MX MX2011013453A patent/MX2011013453A/es active IP Right Grant
- 2010-06-28 KR KR1020127002109A patent/KR101701890B1/ko active Active
-
2011
- 2011-12-21 IL IL217121A patent/IL217121B/en active IP Right Grant
-
2016
- 2016-07-01 JP JP2016131194A patent/JP2017018092A/ja active Pending
-
2019
- 2019-01-29 US US16/260,407 patent/US11136570B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012530510A5 (enExample) | ||
| JP2014500714A5 (enExample) | ||
| Boparai et al. | Mini review on antimicrobial peptides, sources, mechanism and recent applications | |
| Singh et al. | Milk-derived antimicrobial peptides: overview, applications, and future perspectives | |
| Kundu | Cationic amphiphilic peptides: Synthetic antimicrobial agents inspired by nature | |
| AU2010288559A8 (en) | New endolysin OBPgpLYS | |
| Brogden et al. | Will new generations of modified antimicrobial peptides improve their potential as pharmaceuticals? | |
| JP2012530509A5 (enExample) | ||
| Svetoch et al. | Diverse antimicrobial killing by Enterococcus faecium E 50-52 bacteriocin | |
| CN102482655B (zh) | 抗微生物剂 | |
| GB201018518D0 (en) | Novel endolysin | |
| EP3058950A3 (en) | Antimicrobial agents | |
| EA201370145A1 (ru) | Антимикробные средства | |
| JP6683601B2 (ja) | 抗菌性ペプチド | |
| JP2018527933A (ja) | 新規なエンドリシンポリペプチド | |
| CN101111256A (zh) | 抗菌肽及其使用方法 | |
| Hao et al. | A review of the design and modification of lactoferricins and their derivatives | |
| CN114341160A (zh) | 包含赖氨酸替换的romo1来源抗微生物肽及其变体 | |
| Pepperney et al. | Antibacterial peptides: opportunities for the prevention and treatment of dental caries | |
| CA3005490A1 (en) | Bacteriocin composition and method | |
| Nagarajan et al. | Peptide therapeutics versus superbugs: highlight on current research and advancements | |
| EP3313862B9 (en) | Broad-spectrum anti-infective peptides | |
| Bommineni et al. | A fowlicidin-1 analog protects mice from lethal infections induced by methicillin-resistant Staphylococcus aureus | |
| SE2151338A1 (en) | Truncated peptides | |
| CN110078799B (zh) | 抗菌肽及其应用 |